Matthew McEwan, DO
Interventional Pain Medicine · Lakewood, WANPI 1699114025
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,094 of the $1,392 with a category attached, or 78.6%. 10 manufacturers reported payments, led by Boston Scientific at 36.2% of the total. Reporting peaked in 2023 at $441 and has fallen 82.3% since, to $78 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in WA, where the typical reported total is $2,704.
Across 33 payments — averaging $42.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$504
- Medtronic$257
- Nevro Corp.$232
- Abbott$165
- Amgen$75
- Acera Surgical, Inc.$52
- plus $108 from 4 others
What the payments were for
- Grants$29821%
- Food & beverage$1,09479%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $504 |
| Medtronic | 6 | $257 |
| Nevro Corp. | 4 | $232 |
| Abbott | 7 | $165 |
| Amgen | 4 | $75 |
| Acera Surgical, Inc. | 1 | $52 |
| UCB, Inc. | 2 | $31 |
| Axonics, Inc. | 1 | $28 |
| Globus Medical | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,392 in reported general payments places this provider in the 35th percentile of 30 interventional pain medicine providers in Washington.
See all interventional pain medicine providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 223 | $5,870 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 187 | $3,846 |
| Oxycodone Hcl | 218 | $3,205 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $2,669 |
| Morphine Sulfate ErMorphine Sulfate | 68 | $1,489 |
| Tramadol Hcl | 120 | $1,211 |
| Gabapentin | 78 | $1,006 |
| Pregabalin | 56 | $653 |
| Cyclobenzaprine Hcl | 31 | $457 |
| Methocarbamol | 13 | $396 |
| Baclofen | 31 | $246 |
| Tizanidine Hcl | 28 | $174 |
| Diazepam | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lakewood
- Kyong KimLakewood$23K
- Ray BakerKirkland$1.2M
- Daniel NelsonKirkland$29K
- Hyun HongOlympia$16K
- Glen DavidSeattle$14K
- Kiang Yien CheungTacoma$12K
- Diyan RazaSeattle$12K
- Kathy WangPuyallup$11K
- Allen ShohamRichland$8K
- Kashif SaeedTacoma$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.